NVO logo

Novo-Nordisk A/S

NVO

NVO: With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

more

Show NVO Financials

Chart and Financial Data provided by TradingView

$NVO stock is featured in our Congress Long-Short, Congress Sells, and Tom Carper strategies.

See All Strategies
All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of NVO by members of U.S. Congress

Politician Type Traded
Daniel Goldman House / D Sale $100,001 - $250,000 Jul. 12, 2023
Daniel Goldman House / D Sale $250,001 - $500,000 Jul. 10, 2023
Katherine M. Clark House / D Sale $1,001 - $15,000 Sep. 16, 2021
Katherine M. Clark House / D Purchase $1,001 - $15,000 Nov. 05, 2020
Katherine M. Clark House / D Purchase $1,001 - $15,000 Nov. 05, 2020
Carper, Thomas R. Senate / D Purchase $1,001 - $15,000 Apr. 02, 2020
Mikie Sherrill House / D Sale $1,001 - $15,000 Feb. 20, 2020
Mikie Sherrill House / D Sale $1,001 - $15,000 May. 28, 2019
Capito, Shelley Moore Senate / R Sale (Full) $1,001 - $15,000 Mar. 11, 2019
Capito, Shelley Moore Senate / R Purchase $1,001 - $15,000 Sep. 08, 2017
Katherine M. Clark House / D Sale $1,001 - $15,000 Jan. 05, 2017
Katherine M. Clark House / D Sale $1,001 - $15,000 Jan. 05, 2017
Katherine M. Clark House / D Purchase $1,001 - $15,000 Oct. 11, 2016
Katherine M. Clark House / D Purchase $1,001 - $15,000 Oct. 11, 2016
Robert J. Wittman House / R Purchase $1,001 - $15,000 Sep. 15, 2015
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by NVO's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard
Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Selective elimination of erosive cells Jul. 11, 2023
  • Patent Title: Drug delivery system with multipolar magnet and sensor system Jun. 27, 2023
  • Patent Title: Cartridge holder assembly for drug delivery device Jun. 13, 2023
  • Patent Title: Method for using insulin degludec for the improvement of glycemic control and reduction of acute and long-term diabetes complications Jun. 13, 2023
  • Patent Title: Compositions and methods for inhibiting mitochondria amidoxime reducing component 1 (marc1) expression May. 23, 2023
  • Patent Title: Bifunctional compounds comprising insulin peptides and egf(a) peptides May. 16, 2023
  • Patent Title: Power unit for drug delivery device May. 16, 2023
  • Patent Title: Gip derivatives and uses thereof Apr. 25, 2023
  • Patent Title: Spring straining mechanism for torsion spring based device Apr. 25, 2023
  • Patent Title: Plunger sub-assembly for a prefilled medicament injector, a prefilled medicament injector and method for assembling a prefilled medical injector Apr. 18, 2023
  • Patent Title: Anti-transthyretin antibodies Apr. 18, 2023
  • Patent Title: Systems and methods for optimization of bolus timing relative to meal events Apr. 18, 2023
  • Patent Title: Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid Apr. 11, 2023
  • Patent Title: Dose capturing assembly with secondary image analysis feature Apr. 11, 2023
  • Patent Title: Process of spray drying of glp-1 peptide Apr. 04, 2023
  • Patent Title: Accessory device for drug delivery device Mar. 07, 2023
  • Patent Title: Logging device for drug delivery device Feb. 28, 2023
  • Patent Title: Compositions and methods for inhibiting nuclear receptor subfamily 1 group h member 3 (nr1h3) expression Feb. 14, 2023
  • Patent Title: Glp-1 derivatives and uses thereof Feb. 07, 2023
  • Patent Title: Systems and methods for analysis of insulin regimen adherence data Jan. 24, 2023
  • Patent Title: Rotary dosage sensing module for and in a disposable pen drug delivery device Dec. 27, 2022
  • Patent Title: Double-acylated glp-1 derivatives Dec. 06, 2022
  • Patent Title: Systems and methods for the determination of insulin sensitivity Dec. 06, 2022
  • Patent Title: Prefilled drug delivery device with reduced air gap Nov. 29, 2022
  • Patent Title: Insulin analogues and uses thereof Nov. 15, 2022
  • Patent Title: Needle unit with floating needle hub Nov. 08, 2022
  • Patent Title: Semaglutide for use in medicine Oct. 25, 2022
  • Patent Title: Oligomer extended insulin-fc conjugates Oct. 18, 2022
  • Patent Title: Regimen adherence measure for insulin treatment based on glucose measurements and insulin pen data Oct. 11, 2022
  • Patent Title: Drug delivery device with zero position adjustment feature Oct. 11, 2022
  • Patent Title: Stabilised protein solutions Oct. 11, 2022
  • Patent Title: Temperature based plasmid regulation system Oct. 11, 2022
  • Patent Title: Drug delivery device with slim drive mechanism Oct. 04, 2022
  • Patent Title: Systems and methods for adjusting a basal/bolus ratio in an insulin regimen Oct. 04, 2022
  • Patent Title: Injection device with torsion spring and rotatable display Sep. 20, 2022
  • Patent Title: Flow communication unit with preservative Sep. 13, 2022
  • Patent Title: Piston rod brake mechanism Aug. 02, 2022
  • Patent Title: End-of-content mechanism Aug. 02, 2022
  • Patent Title: Drug delivery system with dose capturing Aug. 02, 2022
  • Patent Title: Mechanism for reducing risk of drug contamination Jul. 26, 2022
  • Patent Title: Methods for treating il-6 mediated inflammation without immunosuppression Jul. 12, 2022
  • Patent Title: Prefilled injection device with cleaning chamber Jul. 12, 2022
  • Patent Title: Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid Jul. 12, 2022
  • Patent Title: Mechanism for sequential dose delivery Jul. 12, 2022
  • Patent Title: Systems and methods for estimating the risk of a future hypoglycemic event Jun. 28, 2022
  • Patent Title: Flexible electronic label device Jun. 28, 2022
  • Patent Title: Drug injection device with deflectable transducers Jun. 28, 2022
  • Patent Title: Basal titration with adaptive target glucose level Jun. 28, 2022
  • Patent Title: Injection device Jun. 21, 2022
  • Patent Title: Drug delivery device with sound transducer Jun. 14, 2022
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of NVO in WallStreetBets Daily Discussion

NVO News

Recent insights relating to NVO

CNBC Recommendations

Recent picks made for NVO stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NVO

Corporate Flights

Flights by private jets registered to NVO